Ruhi Khan Overview
- Investor Type
- Angel
- Investments
- 1
- Portfolio
- 1
Ruhi Khan General Information
Description
On November 4, 2021, the Board of Directors of Caribou Biosciences, Inc., a Delaware corporation announced that Ruhi Khan appoint as its chief business officer. Ms. Khan most recently was the founder of an advisory firm that provided business development and finance advice to life science companies. In this role she had extensive senior management experience as head of business development for several oncology-focused companies. Previously, she served as head and vice president of business development for Acorda Therapeutics, Inc. Prior to Acorda, she worked in a similar capacity at Lexicon Pharmaceuticals, Inc. She started her career in venture capital with Fidelity Biosciences Group (now F-Prime Capital) and MPM Capital Advisors LLC. Ms. Khan holds an M.B.A. in health care management from The Wharton School, University of Pennsylvania, and an A.B. in biology from Harvard College.
Contact Information
Primary Investor Type
Angel (individual)
Primary Office
- 2929 7th Street
- Suite 105
- Berkeley, CA 94710
- United States
+1 (510) 000-0000
Ruhi Khan Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 000000000000 | 01-Feb-2015 | 0000 00000 | 00000 | IT Consulting and Outsourcing | Generating Revenue | 0000 0000 |
Ruhi Khan Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialRuhi Khan Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Ruhi Khan | Angel Investor | 0 | Berkeley, CA |